Prevalence of and Risk Factors for Vancomycin-Resistant Staphylococcus aureus Precursor Organisms in Southeastern Michigan

被引：9

作者：

Albrecht, Valerie S. ^{[1
]}

Zervos, Marcus J. ^{[2
]}

Kaye, Keith S. ^{[3
]}

Tosh, Pritish K. ^{[1
,4
,5
]}

Arshad, Samia ^{[2
]}

Hayakawa, Kayoko ^{[3
]}

Kallen, Alexander J. ^{[1
]}

McDougal, Linda K. ^{[1
]}

Limbago, Brandi M. ^{[1
]}

Guh, Alice Y. ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30329 USA

[2] Henry Ford Hlth Syst, Div Infect Dis, Detroit, MI USA

[3] Detroit Med Ctr, Div Infect Dis, Detroit, MI USA

[4] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30329 USA

[5] Mayo Clin, Div Infect Dis, Rochester, MN USA

来源：

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | 2014年 / 35卷 / 12期

关键词：

UNITED-STATES; ENTEROCOCCUS; PLASMID;

D O I：

10.1086/678605

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

We assessed for vancomycin-resistant Staphylococcus aureus (VRSA) precursor organisms in southeastern Michigan, an area known to have VRSA. The prevalence was 2.5% (pSK41-positive methicillin-resistant S. aureus, 2009-2011) and 1.5% (Inc18-positive vancomycin-resistant Enterococcus, 2006-2013); Inc18 prevalence significantly decreased after 2009 (3.7% to 0.82%). Risk factors for pSK41 included intravenous vancomycin exposure.

引用

页码：1531 / 1534

页数：4

共 50 条

[21] Vancomycin-resistant Staphylococcus aureus in the clinic:: Not quite armageddon
Bush, K
CLINICAL INFECTIOUS DISEASES, 2004, 38 (08) : 1056 - 1057
[22] Vancomycin-resistant Staphylococcus aureus occurs in South Africa
Ferraz, V
Dusé, AG
Kassel, M
Black, AD
Ito, T
Hiramatsu, K
SOUTH AFRICAN MEDICAL JOURNAL, 2000, 90 (11): : 1113 - 1113
[23] Vancomycin-resistant Staphylococcus aureus in Nepal: an impending crisis?
Khanal, B.
NEPALESE JOURNAL OF OPHTHALMOLOGY, 2012, 4 (01) : 197 - 198
[24] Vancomycin-resistant Staphylococcus aureus: A real and present danger?
Hamilton-Miller, JM
INFECTION, 2002, 30 (03) : 118 - 124
[25] VanA-Type Vancomycin-Resistant Staphylococcus aureus
Perichon, Bruno
Courvalin, Patrice
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) : 4580 - 4587
[26] Quinupristin/Dalfopristin in Vancomycin-Resistant Staphylococcus aureus Endophthalmitis
Stroh, Edward M.
ARCHIVES OF OPHTHALMOLOGY, 2012, 130 (10) : 1323 - 1324
[27] Vancomycin-resistant Staphylococcus aureus:: Infection control considerations
Wenzel, RP
Edmond, MB
CLINICAL INFECTIOUS DISEASES, 1998, 27 (02) : 245 - 249
[28] Analysis of the genetic diversity of vancomycin-resistant Staphylococcus aureus
Melo, GB
Melo, MC
Gama, AP
Carvalho, KS
Jesus, TC
Bonetti, AM
Filho, PPG
BRAZILIAN JOURNAL OF MICROBIOLOGY, 2005, 36 (02) : 126 - 130
[29] Genomic Analysis of the Emergence of Vancomycin-Resistant Staphylococcus aureus
Kobayashi, Scott D.
Musser, James M.
DeLeo, Frank R.
MBIO, 2012, 3 (04):
[30] Methicillin- and Vancomycin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Isolated from Hospital Foods: Prevalence and Antimicrobial Resistance Patterns
Asma Afshari
Sanaz Taheri
Mohammad Hashemi
Abdolreza Norouzy
Mohsen Nematy
Sara Mohamadi
Current Microbiology, 2022, 79

← 1 2 3 4 5 →